Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: An Eastern Cooperative Oncology Group pilot study: Editorial comment (I)

M. J. Droller

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1126
Number of pages1
JournalJournal of Urology
Volume144
Issue number5
DOIs
StatePublished - 1990

Cite this